OpenAlex
PricingAboutJobs
Log inGet started
Work

Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis

HTML

Year: 2014
Type: review
Source: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2014.01.032
Authors: Sanghamitra Bandyopadhyay, Jack T. Rogers
Institution: Massachusetts General Hospital
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, amyloid precursor protein, iron homeostasis, amyloid-beta, iron-responsive element, iron regulatory protein 1, ferroportin, alpha-secretase, sAPPα, oxidative stress, paroxetine, deferoxamine, anti-amyloid therapy
SDG: Good health and well-being

Open Access status: green

Funders: Alzheimer's Association, National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke
Awards: MLSN Screen of the PD Alpha Synuclein 5'UTR, HTS Molecules Targeting APP 5'untranslated Region(RMI), RNA Therapeutics and Abeta Precursor Protein Translation, RNA Targeted Screens of the Prion 5'UTR, Post Transcriptional Control of hemorrhagic iron damage.
OpenAlex ID: W2026407235
FWCI: 0.821
Cites: 105
Cited by: 80
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security